Prete, R. D., Drago, R., Nardi, F., Bartolini, G., Bellini, E., Rosa, A. D., . . . Kabanova, A. (2024). Robust and cost‐effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ‐TCL1 model of chronic lymphocytic leukemia. Wiley. https://doi.org/10.1002/hem3.134
Style de citation Chicago (17e éd.)Prete, Rosita Del, Roberta Drago, Federica Nardi, Gaia Bartolini, Erika Bellini, Antonella De Rosa, Silvia Valensin, et Anna Kabanova. Robust and Cost‐effective CRISPR/Cas9 Gene Editing of Primary Tumor B Cells in Eµ‐TCL1 Model of Chronic Lymphocytic Leukemia. Wiley, 2024. https://doi.org/10.1002/hem3.134.
Style de citation MLA (9e éd.)Prete, Rosita Del, et al. Robust and Cost‐effective CRISPR/Cas9 Gene Editing of Primary Tumor B Cells in Eµ‐TCL1 Model of Chronic Lymphocytic Leukemia. Wiley, 2024. https://doi.org/10.1002/hem3.134.